This presentation explains 50 practical ways GPT-5 can help pharmaceutical regulatory affairs teams work faster and more accurately.
It’s organized into 10 key areas, each with 5 specific applications, such as:
Regulatory Intelligence – Tracking and summarizing new guidelines worldwide.
Dossier Preparation – Drafting and formatting CTD/eCTD submissions.
Labeling – Checking and creating compliant product labels and leaflets.
Clinical Trial Support – Preparing applications and registry postings.
CMC & Quality – Writing stability reports and control strategies.
Safety & Pharmacovigilance – Summarizing safety data and detecting trends.
Communication with Authorities – Drafting responses and meeting materials.
Post-Approval Management – Handling renewals, variations, and tracking deadlines.
Training – Creating onboarding and SOP training materials.
Process Automation – Extracting data, setting reminders, and building dashboards.
The core message: GPT-5 can automate routine tasks, improve compliance, and give teams more time for strategic work — but AI outputs must still be reviewed by human experts.
Related topics: